Total Payments
$1,581
2019 Payments
$508.03
Companies
39
Transactions
79
Medicare Patients
335
Medicare Billing
$115,870
Payment Breakdown by Category
Food & Beverage$1,581 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,581 | 79 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| iCAD, Inc | $253.72 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $110.03 | 6 | $0 (2019) |
| Amgen Inc. | $80.91 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $69.88 | 4 | $0 (2019) |
| GENZYME CORPORATION | $67.79 | 4 | $0 (2019) |
| Astellas Pharma US Inc | $67.72 | 4 | $0 (2019) |
| Foundation Medicine, Inc. | $65.01 | 2 | $0 (2018) |
| Genentech USA, Inc. | $56.32 | 4 | $0 (2018) |
| Eisai Inc. | $54.26 | 3 | $0 (2019) |
| ASD Specialty Healthcare, LLC | $51.54 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $508.03 | 31 | AstraZeneca Pharmaceuticals LP ($78.02) |
| 2018 | $624.78 | 29 | iCAD, Inc ($126.86) |
| 2017 | $448.66 | 19 | iCAD, Inc ($126.86) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Oncology | ||||||
| 12/04/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Oncology | ||||||
| 12/03/2019 | Fortovia Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $8.47 | General |
| 11/21/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: Anemia | ||||||
| 10/14/2019 | Lexicon Pharmaceuticals, Inc. | Xermelo (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Carcinoid Syndrome Diarrhea | ||||||
| 10/11/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Anemia | ||||||
| 10/10/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Oncology | ||||||
| 10/01/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $15.74 | General |
| 09/20/2019 | Astellas Pharma US Inc | XOSPATA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Oncology | ||||||
| 09/11/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: Oncology | ||||||
| 09/10/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.20 | General |
| 08/27/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $11.13 | General |
| Category: Hematology/Oncology | ||||||
| 08/19/2019 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Oncology | ||||||
| 08/15/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Oncology | ||||||
| 08/13/2019 | Lexicon Pharmaceuticals, Inc. | Xermelo (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Carcinoid Syndrome Diarrhea | ||||||
| 08/08/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Oncology | ||||||
| 08/07/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: ONCOLOGY | ||||||
| 08/06/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Hematology / Oncology | ||||||
| 08/05/2019 | Dova Pharmaceuticals | Doptelet (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Hepatology | ||||||
| 07/30/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Oncology | ||||||
| 07/24/2019 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.46 | General |
| Category: Oncology | ||||||
| 07/23/2019 | Mylan Institutional Inc. | Fulphila (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 18 | 335 | 2,769 | $422,872 | $115,870 |
Total Patients
335
Total Services
2,769
Medicare Billing
$115,870
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2020 | 16 | 169 | $170,521 | $49,881 | 29.3% |
| 78815 | Nuclear medicine study with ct imaging skull base to mid-thigh | Office | 2020 | 19 | 19 | $72,200 | $21,915 | 30.4% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Office | 2020 | 11 | 111 | $51,726 | $11,116 | 21.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 14 | 56 | $33,600 | $9,789 | 29.1% |
| 77427 | Radiation treatment management, 5 treatments | Office | 2020 | 14 | 38 | $18,050 | $5,922 | 32.8% |
| 77290 | Management of radiation therapy, simulation, complex | Office | 2020 | 13 | 16 | $19,776 | $5,444 | 27.5% |
| 77336 | Radiation therapy consultation per week | Office | 2020 | 21 | 42 | $6,678 | $2,727 | 40.8% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2020 | 23 | 23 | $11,224 | $1,861 | 16.6% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2020 | 11 | 11 | $6,919 | $1,727 | 25.0% |
| 77300 | Calculation of radiation therapy dose | Office | 2020 | 15 | 27 | $4,860 | $1,373 | 28.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 30 | $4,620 | $1,023 | 22.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 18 | $4,194 | $807.38 | 19.3% |
| 71260 | Ct scan chest with contrast | Office | 2020 | 14 | 14 | $9,814 | $707.63 | 7.2% |
| 84153 | Psa (prostate specific antigen) measurement | Office | 2020 | 35 | 35 | $2,205 | $630.70 | 28.6% |
| 77333 | Radiation treatment devices, design and construction, intermediate | Facility | 2020 | 13 | 13 | $1,391 | $395.95 | 28.5% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2020 | 14 | 14 | $952.00 | $273.09 | 28.7% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2020 | 15 | 2,092 | $2,092 | $159.42 | 7.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 40 | 41 | $2,050 | $118.10 | 5.8% |
About Dr. Gregory Echt, MD
Dr. Gregory Echt, MD is a Radiation Oncology healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689657298.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Echt, MD has received a total of $1,581 in payments from pharmaceutical and medical device companies, with $508.03 received in 2019. These payments were reported across 79 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($1,581).
As a Medicare-enrolled provider, Echt has provided services to 335 Medicare beneficiaries, totaling 2,769 services with total Medicare billing of $115,870. Data is available for 1 year (2020–2020), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Irving, TX
- Active Since 11/29/2005
- Last Updated 11/20/2018
- Taxonomy Code 2085R0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689657298
Products in Payments
- Axxent Controller (Device) $253.72
- JEVTANA (Drug) $94.33
- FOUNDATIONONE (Device) $65.01
- Kyprolis (Biological) $62.27
- Lenvima (Drug) $54.26
- Avastin (Biological) $45.16
- JADENU (Drug) $41.94
- JAKAFI (Drug) $40.57
- IMFINZI (Drug) $39.12
- PROVENGE (Drug) $38.88
- Stivarga (Drug) $35.16
- Axumin (Drug) $34.48
- Lupron (Drug) $33.20
- Olympus Capital Accessories (Device) $32.90
- Docetaxel (Drug) $32.69
- LYNPARZA (Drug) $32.01
- XARELTO (Drug) $30.14
- Xermelo (Drug) $29.96
- PROMACTA (Drug) $27.94
- INJECTAFER (Drug) $26.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.